Fluorescence-based biochemical analysis of human hepatitis B virus reverse transcriptase activity

Area of Science:

• Virology
• Molecular Biology
• Biochemistry

Background:

• The priming step of hepatitis B virus (HBV) reverse transcription is understood, but the elongation phase remains unclear.
• HBV polymerase is a key target for antiviral therapies, necessitating a deeper understanding of its function.
• Previous research has focused on priming, leaving the elongation mechanism largely unexplored.

Purpose of the Study:

• To investigate the elongation activity of the HBV polymerase reverse transcriptase (RT).
• To characterize the enzymatic properties and cofactor dependencies of HBV RT elongation.
• To compare the elongation activity across different HBV genotypes.

Main Methods:

• Expression and partial purification of HBV RT-RNase H sequences (amino acids 304-843) in E. coli.
• Assay of RT elongation activity using fluorescently tagged primers and homopolymeric RNA templates.
• Analysis of cofactor dependency (divalent cations) and deoxynucleotide substrate affinity.

Main Results:

• HBV RT elongation activity was dependent on both Mg2+ and Mn2+.
• The enzyme exhibited low affinity for purine deoxynucleotides, a characteristic shared with successful antiviral drugs like adefovir, tenofovir, and entecavir.
• The polymerization rate was lower compared to human immunodeficiency virus RT.
• All tested HBV genotypes showed similar RT activity, with genotype B displaying enhanced elongation activity.

Conclusions:

• The divalent cation dependency and low purine affinity of HBV RT elongation are key features relevant to antiviral drug development.
• The observed lower polymerization rate compared to HIV RT may influence therapeutic strategies.
• Genotypic variations, particularly the increased activity in genotype B, could have implications for HBV pathogenesis and treatment response.